This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: CLO26-124: Comparative Outcomes of CDK4/6 Inhibitors and Endocrine Therapy in HER2-Low Versus HER2-Negative Metastatic Breast Cancer: A Retrospective Nationwide Cohort Study From Qatar, Journal of the National Comprehensive Cancer Network, March 2026, Harborside Press, LLC,
DOI: 10.6004/jnccn.2025.7354.
You can read the full text:
The following have contributed to this page
